MCM
VRTX icon

McRae Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

McRae Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Sell
33,191
-932
-3% -$413K 3.24% 12
2026
Q1 		$15.2M Sell
34,123
-1,435
-4% -$669K 3.16% 12
2025
Q4 		$16.1M Buy
35,558
+2,399
+7% +$1.03M 3.29% 13
2025
Q3 		$13M Buy
33,159
+2,706
+9% +$1.13M 2.58% 17
2025
Q2 		$13.6M Buy
30,453
+125
+0.4% +$57.6K 2.78% 16
2025
Q1 		$14.7M Sell
30,328
-750
-2% -$350K 3.1% 12
2024
Q4 		$12.5M Sell
31,078
-802
-3% -$372K 2.45% 19
2024
Q3 		$14.8M Sell
31,880
-1,640
-5% -$788K 2.89% 15
2024
Q2 		$15.7M Sell
33,520
-420
-1% -$182K 3.58% 11
2024
Q1 		$14.2M Sell
33,940
-785
-2% -$332K 3.11% 15
2023
Q4 		$14.1M Sell
34,725
-543
-2% -$201K 3.53% 12
2023
Q3 		$12.3M Sell
35,268
-312
-0.9% -$109K 3.63% 11
2023
Q2 		$12.5M Buy
35,580
+231
+0.7% +$77.8K 3.56% 12
2023
Q1 		$11.1M Sell
35,349
-410
-1% -$123K 3.21% 14
2022
Q4 		$10.3M Sell
35,759
-606
-2% -$185K 3.02% 14
2022
Q3 		$10.5M Sell
36,365
-130
-0.4% -$37.4K 3.2% 13
2022
Q2 		$10.3M Buy
36,495
+7,995
+28% +$2.14M 2.79% 15
2022
Q1 		$7.44M Buy
+28,500
New +$6.76M 1.68% 26

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

McRae Capital Management's VRTX Position: Q2 2026 in Review

McRae Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.7% in Q2 2026, selling an estimated $413K and leaving 33,191 shares worth $16.5M. The position accounts for 3.24% of the portfolio, ranked #12.

McRae Capital Management first reported a position in VRTX in Q1 2022 and has held it in 18 quarters since. 256 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • McRae Capital Management held 33,191 shares of Vertex Pharmaceuticals worth $16.5M as of Q2 2026.
  • McRae Capital Management sold 932 Vertex Pharmaceuticals shares in Q2 2026, an estimated $413K.
  • Vertex Pharmaceuticals made up 3.24% of McRae Capital Management's portfolio in Q2 2026, its #12 holding.
  • McRae Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • 256 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.